{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:14:33Z","timestamp":1790144073581,"version":"4.0.1"},"reference-count":84,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Women's Health"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The Surveillance, Epidemiology, and End Result (SEER) database shows a variable increase in endometrial cancer incidence over time. The objective of this review was to examine published endometrial cancer rates and potential etiologies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Endometrial cancer incidence was obtained from the SEER Program database from 1975 through 2014, and a test for trend in incidence was calculated. Changes in risk factors thought to be associated with endometrial cancer, including age, obesity, diabetes, diet and exercise, reproductive factors, and medications (hormone therapy [HT] including Food and Drug Administration [FDA]-approved and non-FDA\u2013approved [compounded] estrogens and progestogens, tamoxifen, and hormonal contraceptives) were found through PubMed searches. Temporal trends of risk factors were compared with endometrial cancer trends from SEER.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Although endometrial cancer rates were constant from 1992 to 2002 (women 50\u201374 years of age), they increased 2.5% annually with a 10% increase from 2006 to 2012 (trend test 0.82). Use of approved prescription estrogen\u2013progestogen combination products decreased after the publication of the Women's Health Initiative (WHI) data, whereas other risk factors either remained constant or decreased during the same time; however, compounded bioidentical HT (CBHT) use increased coincident with the endometrial cancer increase.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Endometrial cancer rate increases after the first publication of WHI data in 2002 may be associated with the decreased use of approved estrogen\u2013progestogen therapy, the increase in CBHT use, and the prevalence of obesity and diabetes; potential relationships require further evaluation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/jwh.2018.6956","type":"journal-article","created":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T11:18:36Z","timestamp":1543403916000},"page":"237-243","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":142,"title":["Increased Incidence of Endometrial Cancer Following the Women's Health Initiative: An Assessment of Risk Factors"],"prefix":"10.1177","volume":"28","author":[{"given":"Ginger D.","family":"Constantine","sequence":"first","affiliation":[{"name":"LLC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Kessler","sequence":"additional","affiliation":[{"name":"LLC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelli","family":"Graham","sequence":"additional","affiliation":[{"name":"TherapeuticsMD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Goldstein","sequence":"additional","affiliation":[{"name":"New York University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2019,2,14]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21442"},{"key":"e_1_3_3_3_2","unstructured":"National Cancer Institute (NIH). Cancer Stat Facts: Endometrial Cancer. Available at: https:\/\/seer.cancer.gov\/statfacts\/html\/corp.html Accessed November27 2017."},{"key":"e_1_3_3_4_2","unstructured":"National Cancer Institute (NIH). Overview of the SEER program. Available at: https:\/\/seer.cancer.gov\/about\/overview.html Accessed November27 2017."},{"key":"e_1_3_3_5_2","unstructured":"Howlader N Noone AM Krapcho M et al. SEER Cancer Statistics Review 1975\u20132014; Cancer of the Corpus and Uterus. National Cancer Institute. Bethesda MD Available at: https:\/\/seer.cancer.gov\/csr\/1975_2014\/results_single\/sect_07_table. 01.pdf based on November 2016 SEER data submission posted to the SEER website April 2017. Accessed August2 2017."},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2013.03.008"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.3.321"},{"key":"e_1_3_3_8_2","unstructured":"American Cancer Society. Endometrial cancer causes risk factors and prevention. Available at: https:\/\/www.cancer.org\/content\/dam\/CRC\/PDF\/Public\/8610.00.pdf Accessed November27 2017."},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0029-7844(94)00383-O"},{"key":"e_1_3_3_10_2","first-page":"CD000402","article-title":"Hormone therapy in postmenopausal women and risk of endometrial hyperplasia","author":"Furness S","year":"2012","unstructured":"Furness S, , Roberts H, , Marjoribanks J, , Lethaby A. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database Syst Rev, 2012:CD000402.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2016.05.013"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03530290040035"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66455-0"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq300"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.13.1739"},{"key":"e_1_3_3_16_2","unstructured":"Howlader N Noone AM Krapcho M et al. SEER Cancer Statistics Review (CSR) 1975\u20132014. National Cancer Institute. Bethesda MD. Available at: https:\/\/seer.cancer.gov\/csr\/1975_2014 (https:\/\/seer.cancer.gov\/csr\/1975_2014\/). Accessed January25 2018."},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197512042932303"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197512042932302"},{"key":"e_1_3_3_19_2","first-page":"65","volume-title":"Endometrial cancer","author":"Whitehead MI","year":"1978","unstructured":"Whitehead MI, , Campbell S. Endometrial histology, uterine bleeding, and oestrogen levels in menopausal women receiving oestrogen therapy and oestrogen\/progestogen therapy. In: Brush M, , Taylor RWT, , King RJB, eds. Endometrial cancer. London: Bailliere Tindall, 1978:65\u201380."},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(78)90015-4"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197606032942303"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(13)90437-3"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv350"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000921"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e3181a02b44"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e31824bb039"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.1.47"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000296714.12226.0f"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e3181a48c4e"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181f386bb"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000956"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000001054"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000463542.93964.91"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1514242"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2015.02.027"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e318268049e"},{"key":"e_1_3_3_37_2","first-page":"462","article-title":"Specialty compounding for improved patient care: A national survey of compounding pharmacists","volume":"10","author":"Huffman DCRP","year":"2006","unstructured":"Huffman DCRP, , Holmes ERPM. Specialty compounding for improved patient care: A national survey of compounding pharmacists. Int J Pharm Compd, 2006; 10:462\u2013468.","journal-title":"Int J Pharm Compd"},{"key":"e_1_3_3_38_2","first-page":"74","article-title":"Specialty compounding for improved patient care: 2006 national survey of compounding pharmacists","volume":"12","author":"Huffman DC","year":"2008","unstructured":"Huffman DC, , Holmes ER. Specialty compounding for improved patient care: 2006 national survey of compounding pharmacists. Int J Pharm Compd, 2008; 12:74\u201382.","journal-title":"Int J Pharm Compd"},{"key":"e_1_3_3_39_2","first-page":"172","article-title":"Utilization and costs of compounded medications for commercially insured patients, 2012\u20132013","volume":"22","author":"McPherson T","year":"2016","unstructured":"McPherson T, , Fontane P, , Iyengar R, , Henderson R. Utilization and costs of compounded medications for commercially insured patients, 2012\u20132013. J Manag Care Spec Pharm, 2016; 22:172\u2013181.","journal-title":"J Manag Care Spec Pharm"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000567"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000420"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000553"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2014.4770"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2007.tb01210.x"},{"issue":"1","key":"e_1_3_3_45_2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/00009577-201505001-00056","article-title":"Two case of atypical endometrial hyperplasia associated with \u201cbioidentical\u201d hormone replacement therapy: IGCS-0084 Uterine Cancer, including Sarcoma","volume":"25","author":"Dezman VL","year":"2015","unstructured":"Dezman VL, , Gersak MZ, , Gersak K. Two case of atypical endometrial hyperplasia associated with \u201cbioidentical\u201d hormone replacement therapy: IGCS-0084 Uterine Cancer, including Sarcoma. Int J Gynecol Cancer, 2015; 25 Suppl 1:71.","journal-title":"Int J Gynecol Cancer"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-06-0675"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021423"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1053>3.0.CO;2-T"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.48.2596"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1988.44"},{"key":"e_1_3_3_51_2","unstructured":"National Center for Health Statistics. Prevalence of overweight obesity and extreme obesity among adults: United States 1960\u20131962 through 2011\u20132012. September 2014. Available at: https:\/\/www.cdc.gov\/nchs\/data\/hestat\/obesity_adult_11_12\/obesity_adult_11_12.htm Accessed December1 2017."},{"key":"e_1_3_3_52_2","unstructured":"National Center for Health Statistics. Table 58 (page 1 of 7). Normal weight overweight and obesity among adults aged 20 and over by selected characteristics: United States selected years 1988\u20131994 through 2011\u20132014. Available at: https:\/\/www.cdc.gov\/nchs\/data\/hus\/2015\/058.pdf Accessed December1 2017."},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0681-5"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.11494"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1139\/y11-055"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a008707"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24672"},{"key":"e_1_3_3_58_2","first-page":"4791","article-title":"Risk factors for endometrial cancer: Results from a Hospital-Based Case-Control Study","volume":"17","author":"Ghanbari Andarieh M","year":"2016","unstructured":"Ghanbari Andarieh M, , Agajani Delavar M, , Moslemi D, , Esmaeilzadeh S. Risk factors for endometrial cancer: Results from a Hospital-Based Case-Control Study. Asian Pac J Cancer Prev, 2016; 17:4791\u20134796.","journal-title":"Asian Pac J Cancer Prev"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2013-0286"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.111.1.110"},{"key":"e_1_3_3_61_2","unstructured":"Monte LM Ellis RR. Fertility of women in the United States: 2012 population characteristics. Hyattsville MD. Available at: https:\/\/www.census.gov\/content\/dam\/Census\/library\/publications\/2014\/demo\/p20-575.pdf Accessed October2017."},{"key":"e_1_3_3_62_2","unstructured":"Mosher WD Jones J. Use of contraception in the United States: 1982\u20132008. Available at: https:\/\/www.cdc.gov\/nchs\/data\/series\/sr_23\/sr23_029.pdf Accessed October2017."},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2017.10.003"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2017.02.002"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00212-0"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25050"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-10-0076"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2007.11.011"},{"key":"e_1_3_3_69_2","first-page":"1","article-title":"Trends in long-acting reversible contraception use among U.S. women aged 15\u201344","author":"Branum AM","year":"2015","unstructured":"Branum AM, , Jones J. Trends in long-acting reversible contraception use among U.S. women aged 15\u201344. NCHS Data Brief, 2015:1\u20138.","journal-title":"NCHS Data Brief"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002390"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2011-0014"},{"key":"e_1_3_3_72_2","unstructured":"National Cancer Institute. SEER Cancer Statistics Review 1975\u20132014; Cancer of the Ovary. Available at: https:\/\/seer.cancer.gov\/csr\/1975_2014\/results_merged\/sect_21_ovary.pdf Accessed December1 2017."},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji372"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-09-0930"},{"key":"e_1_3_3_75_2","first-page":"243","article-title":"Physical activity and endometrial cancer risk: A review of the current evidence, biologic mechanisms and the quality of physical activity assessment methods","volume":"18","author":"Cust AE","year":"2007","unstructured":"Cust AE, , Armstrong BK, , Friedenreich CM, , Slimani N, , Bauman A. Physical activity and endometrial cancer risk: A review of the current evidence, biologic mechanisms and the quality of physical activity assessment methods. Cancer Causes Control, 2007; 18:243\u2013258.","journal-title":"Cancer Causes Control"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-06-0742"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605902"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168175"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.06.002"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.3109\/17453671003587101"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1081\/DDC-200040251"},{"key":"e_1_3_3_82_2","unstructured":"Ramin CJ. The hormone hoax thousands fall for. More.com. October 2013 134\u2013156."},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2010.0714"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.GME.0000094356.92081.EF"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1271"}],"container-title":["Journal of Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jwh.2018.6956","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jwh.2018.6956","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jwh.2018.6956","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:48:27Z","timestamp":1777657707000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jwh.2018.6956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1089\/jwh.2018.6956"],"URL":"https:\/\/doi.org\/10.1089\/jwh.2018.6956","relation":{},"ISSN":["1540-9996","1931-843X"],"issn-type":[{"value":"1540-9996","type":"print"},{"value":"1931-843X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}